Maryland CC Project
Maryland CC Project
Maryland CC Project
Pickering – Evaluation and Management of Hemoptysis
43 minutes Posted Sep 6, 2018 at 12:00 pm.
0:00
43:48
Download MP3
Show notes

Edward Pickering, MD, Assistant Professor of Medicine, Division of Pulmonary & Critical Care Medicine at University of Maryland SOM and Director, Interventional Pulmonology at Baltimore VAMC, presents the weekly multi-departmental critical care fellows’ lecture on “Evaluation and Management of Hemoptysis: From a Trickle to Projectile.”









Lecture summary by Dr. Jason Nam



Definition of Massive Hemoptysis



* No uniform cut off value or definition* Life threatening is a better term. Chronic respiratory
failure- 50mL/hr can cause hypoxemia and instability. * Definition- airway
obstruction from clots, hypoxemia, need for mechanical ventilation, or
hemodynamic instability.* Don’t want to underestimate
other factors- like ability to protect airway, rate of bleeding, and underlying
co-morbidities. * Etiology- airway disease
(bronchiectasis, neoplasm), parenchymal disease (infection, immunologic,
neoplasm), or vascular causes (AVM, pseudoaneurysm, valvular disease, VTE). * 90% is bronchial artery in
supply. Failed Bronchial artery embolization (BAE)- 25%. Either unsuccessful or
non-bronchial system supply. * Diagnosis and localization:
CXR, traditional CT, multi-detector CT, or bronchoscopy.



Initial management-



* Stabilize the patient, bad
lung down if you know, airway protection, intubation.* Intubate with at least
size>8 ETT clear airway of clot. Lung isolation- protect the good side.
Selective mainstem intubation, Fogarty.  Selective
mainstem intubation. Protect left side when right side is filling up with
blood. * Fogarty balloons– available in multiple sizes. Except for
8Fr, must maintain manual inflation. Make sure to read insert- different
volumes of air/saline for each size.* Bronchial blockers-
available in 5, 7, 9Fr. Spherical or elliptical. 3 ports. Wire loop for guide
via scope. Determine dimensions. Lubricate well. Attach multisport adaptor.   * Topical therapies-Iced
saline aliquots- no randomized trials. Topical epinephrine- unpredictable
absorption. Thrombin- promotes clot formation via fibrin activation. * Multidisciplinary approach.
Most likely, interventional radiology will treat the cause.



Post-tracheostomy bleeding



* Incidence 5%. Timing
narrows differential. First 2-3 days tend to be local factors. Weeks 1-6
tracheo-innominate fistula. * Minor oozing- due to
submucosal vessel or coagulopathy. Treat with gauze, silver nitrate sticks,
correct coagulopathy. More significant bleeding due to thyroid vein/artery,
thyroid isthmus, or suction trauma.



Tracheo-innominate fistula



catastrophic and most feared complication. Peaks around week
3-4. 2 main causes: low tracheostomy (below 4th tracheal ring) or
high-riding innominate artery.



Discussion of various patient scenarios



* Patient scenario #1 with life threatening hemoptysis.
Bronchoscopy shows clots. Clot is your friend because it is causing tamponade.
Bleeding probably distal to the clot. * You see no evidence of
continued bleeding. Biopsy suspicious for squamous cell carcinoma. Patient gets
BAE. 1/3 of patients especially those in malignancy have non-bronchial sources
of bleeding. Good short term success. 2 weeks later- recurrent massive
hemoptysis. Bronchial blocker placed. Patient never received a CTA. Now gets
one, and you see massive RLL pseudo aneurysm. Gets IR coils placed. CTA very
helpful for identifying cause and structure.